186. Effects of a nature-based intervention on cognitive function in older adults with mild cognitive impairment
Abstract Background Mild Cognitive Impairment (MCI) represents a high-risk stage for dementia. Pharmacological treatments for MCI have demonstrated limited efficacy and are frequently associated with adverse effects. Despite recent approvals of Donanemab and Lecanemab, their high cost, complex use, and serious side eff...